In a double-blind , placebo-matched parallel groups study , 50 postmenopausal women ( aged 51-66 y ) were randomly allocated to receive daily treatment with a soy supplement ( Novasoy , 60 mg total isoflavone equivalents/day ) or matching placebo capsules .
